Working together to develop a screening platform to enhance the detection and management of Alzheimer’s disease.
PREDICTOM is an international across sector initiative to bring dementia diagnostics closer to the public through a customisable cognitive and biomarker screening platform.
Latest news
News
PREDICTOM Launches Standardized MRI Protocol to Detect Early Alzheimer’s Risk
PREDICTOM has unveiled a standardized MRI protocol designed to identify early biomarkers of Alzheimer’s disease. With dementia cases in the EU projected to double by 2050, early detection is more critical than ever.
News
New study reveals subtle brain network changes in early Alzheimer’s
A new study from the European research project PREDICTOM shows that even small memory problems can be linked to early changes in the brain, changes that can be measured with a simple brain scan.
News
Starlab and Neuroelectrics Join PREDICTOM to Improve Early Detection of Alzheimer’s Disease
Starlab and Neuroelectrics have officially joined the PREDICTOM project. This EU-funded initiative is working to develop an AI-based tool that can detect signs of Alzheimer’s disease earlier than today’s methods. With dementia cases expected to double in the EU by 2050, early detection is more important than ever for patients, families, and healthcare systems.
Did you know that you can reduce your risk of developing dementia?
The risk of developing dementia is influenced by various factors, with several of them being modifiable by the actions we take on a daily basis. On this page you can learn more about what actions you can take to reduce your risk.
Our mission
PREDICTOM will identify scalable biosignatures for early and accurate diagnosis of Alzheimer’s disease and personalized preventive interventions.
